Literature DB >> 564910

Skeletal muscle acetylcholine receptor. Purification, characterization, and turnover in muscle cell cultures.

J P Merlie, J P Changeux, F Gros.   

Abstract

Acetylcholine receptor has been purified from embryonic skeletal muscle cells grown and allowed to differentiate in tissue culture. The polypeptide composition of purified receptor has been determined by two-dimensional electrophoresis. The purest preparations are composed of a single Mr = 41,000 class of polypeptide which exhibits some charge heterogeneity. By high resolution two-dimensional electrophoresis a spot corresponding to acetylcholine receptor was localized among total proteins of muscle membrane extracts. Synthesis of this component is shown to be developmentally regulated. Quantitative analysis of receptor synthesis and degradation has led to the conclusion that receptor is one of a class of proteins whose synthesis is tightly regulated during terminal steps of myogenesis.

Mesh:

Substances:

Year:  1978        PMID: 564910

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Activity-dependent regulation of gene expression in muscle and neuronal cells.

Authors:  R Laufer; J P Changeux
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

2.  cDNA clone for the alpha subunit of the acetylcholine receptor from the mouse muscle cell line BC3H-1.

Authors:  J P Merlie; R Sebbane; S Gardner; J Lindstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

3.  Appearance and distribution "in situ" of nicotinic acetylcholine receptors in cervical myotomes of young chick embryos. Radioautographic studies by light and electron microscopy.

Authors:  R Meiniel; J P Bourgeois
Journal:  Anat Embryol (Berl)       Date:  1982

4.  Identification of a cDNA clone coding for the acetylcholine binding subunit of Torpedo marmorata acetylcholine receptor.

Authors:  J Giraudat; A Devillers-Thiery; C Auffray; F Rougeon; J P Changeux
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.